VCYT
#1587
Veracyte, Inc. - Common Stock
43.4 3 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.56%
Variación mensual
-6.32%
Variación en los últimos 6 meses
+22.21%
Cambio anual
+17.70%
Cierres anteriores
43.1 9
Open
43.4 3
Mínimo
43.4 3
Máximo
43.4 3
Volumen
97
Financials
- Market Capitalization 3.49 B
- Employee 755
- Founded 2006
- CEO N/A
- Website www.veracyte.com
- Headquarter Delaware, United States
- FIGI BBG001J2M542
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
41.95
Relación precio/flujo de caja
8.46
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1543 |  DNLI Denali Therapeutics Inc. - Common Stock | 23.27 USD | -2.06% | -5.98% | +1.84% | +43.91% | 3.72 B USD | ||
| 1553 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 10.85 USD | -2.16% | -4.32% | +6.37% | +71.95% | 3.68 B USD | ||
| 1596 |  ABCL AbCellera Biologics Inc. - Common Shares | 11.28 USD | -1.74% | -7.69% | +97.89% | +177.83% | 3.46 B USD | ||
| 1620 |  GPCR Structure Therapeutics Inc - American Depositary Shares | 47.13 USD | +2.66% | -5.27% | -1.81% | +76.25% | 3.36 B USD |